Harold S Bernstein, MD, PhD

About Me
Education & Certifications
Publications
Industry Relationships

About Me

Dr. Bernstein is adjunct faculty in the Department of Pediatrics and the Mindich Child Health and Development Institute. Currently, he serves as the President of Research and Development and Chief Medical Officer at Maze Therapeutics, a clinical stage biotechnology company developing genetically-informed precision medicines for kidney, cardiovascular and metabolic diseases.

Language

English

Position

ADJUNCT PROFESSOR | Pediatrics, Cardiology

Research Topics

Drug Design and Discovery

About Me

Language

English

Position

ADJUNCT PROFESSOR | Pediatrics, Cardiology

Research Topics

Drug Design and Discovery

Education

BA, Harvard University

MPhil, Mount Sinai School of Medicine

PhD, Mount Sinai School of Medicine

MD, Mount Sinai School of Medicine

Residency, University of California San Francisco

Fellowship, University of California San Francisco

Postdoctoral Fellowship, Cardiovascular Research Institute/UCSF

Publications

Publications:55

Selected Publications

Plasma microvesicle analysis identifies microRNA 129-5p as a biomarker of heart failure in univentricular heart disease. Sweta Ramachandran, Alexander Lowenthal, Carissa Ritner, Shiri Lowenthal, Harold S. Bernstein. PLoS ONE
Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations. Javed Butler, Carine E. Hamo, James E. Udelson, Christopher O'Connor, Hani N. Sabbah, Marco Metra, Sanjiv J. Shah, Dalane W. Kitzman, John R. Teerlink, Harold S. Bernstein, Gabriel Brooks, Christophe Depre, Mary M. Desouza, Wilfried Dinh, Mark Donovan, Regina Frische-Danielson, Robert J. Frost, Dahlia Garza, Udo Michael Gohring, Jennifer Hellawell, Judith Hsia, Shiro Ishihara, Patricia Kay-Mugford, Joerg Koglin, Marc Kozinn, Christopher J. Larson, Martha Mayo, Li Ming Gan, Pierrre Mugnier, Sekayi Mushonga, Lothar Roessig, Cesare Russo, Afshin Salsali, Carol Satler, Victor Shi, Barry Ticho, Michael Van Der Laan, Clyde Yancy, Norman Stockbridge, Mihai Gheorghiade. Circulation: Heart Failure
Exploring New Endpoints for Patients with Heart Failure with Preserved Ejection Fraction. Javed Butler, Carine E. Hamo, James E. Udelson, Bertram Pitt, Clyde Yancy, Sanjiv J. Shah, Patrice Desvigne-Nickens, Harold S. Bernstein, Richard L. Clark, Christophe Depre, Wilfried Dinh, Andrew Hamer, Patricia Kay-Mugford, Frank Kramer, Martin Lefkowitz, Kelly Lewis, Juan Maya, Simon Maybaum, Mahesh J. Patel, Pia S. Pollack, Lothar Roessig, Sarit Rotman, Afshin Salsali, J. Jason Sims, Michele Senni, Giuseppe Rosano, Preston Dunnmon, Norman Stockbridge, Stefan D. Anker, Michael R. Zile, Mihai Gheorghiade. Circulation: Heart Failure

View All Publications

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Bernstein has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Dr. Bernstein has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.